Is Biogen’s RayThera Acquisition a Game-Changer for Immunology?
The global biotechnology industry witnessed another major acquisition announcement in June 2026. Biogen, one of the world’s leading…
Biogen to Acquire Apellis Pharma in $5.6 Billion Deal to Boost Rare Disease Growth
In one of the biggest biotechnology deals of 2026, Biogen has announced the acquisition of Apellis Pharmaceuticals for…


































































